Lipocine Inc.

Filed a patent for "compositions and methods for treating cns disorders" on Mon, February 12, 2024

Filed a patent for "testosterone dodecanoate compositions and methods" on Thu, January 30, 2025

Filed a patent for "bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters" on Wed, November 22, 2023

Filed a patent for "oral testosterone therapy" on Mon, April 22, 2024

Filed a patent for "oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy" on Thu, July 25, 2024

Filed a patent for "oral allopregnanolone compositions and methods of use" on Thu, August 1, 2024

Filed a patent for "fixed dose oral testosterone undecanoate compositions and use thereof" on Wed, September 21, 2022

Filed a patent for "oral testosterone therapy" on Tue, May 2, 2023

Filed a patent for "method and composition for treating epilepsy" on Thu, December 7, 2023

Filed a patent for "steroidal compositions" on Thu, January 11, 2024

Filed a patent for "oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy" on Thu, May 30, 2024

Filed a patent for "oral allopregnanolone compositions and methods of use" on Thu, May 30, 2024

Filed a patent for "oral allopregnanolone compositions and methods of use" on Mon, August 29, 2022

Filed a patent for "compositions and methods for treating cns disorders" on Thu, May 16, 2024

Filed a patent for "3alpha-oh-5beta-pregnan-20-one compositions and methods for treating central nervous system disorders" on Thu, October 12, 2023

Filed a patent for "compositions and methods for treating cns disorders" on Thu, November 10, 2022

Filed a patent for "(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use" on Thu, October 20, 2022